Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report) traded up 1.2% during trading on Thursday . The company traded as high as $4.15 and last traded at $4.15. 2,003 shares were traded during mid-day trading, an increase of 301% from the average session volume of 500 shares. The stock had previously closed at $4.10.
Sigyn Therapeutics Price Performance
The stock has a 50 day moving average of $3.66 and a 200 day moving average of $4.57.
Sigyn Therapeutics Company Profile
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Recommended Stories
- Five stocks we like better than Sigyn Therapeutics
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Invest in Blue Chip Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Using the MarketBeat Dividend Yield Calculator
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20230214115121&h=45&w=95&zc=2){kind=logo}
